Accelerate your oncology R&D with quality biospecimens & data
We are a key resource for
Pharma & biotech
High-quality clinical specimens for biomarker research, with available histopathology, molecular characterization and treatment follow-up.
+1The Institute of Cancer Research 
Diagnostics companies
Specimens and control tissues for histologic and nucleic-acid assays, including IHC, NGS and multiplex assay development.
+8Walter and Eliza Hall Institute of Medical Research; University of Melbourne; University of Queensland; Wesley Research Institute; University of Technology Sydney; The Prince Charles Hospital; Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital 
AI companies
Whole-slide H&E images, associated clinical records and source tissue for computational pathology and algorithm development.
+2University of Queensland; Princess Alexandra Hospital 
Organizations are identified from author affiliations, patent records and report credits. Their inclusion does not imply a partnership with or endorsement of TriStar.
Samples. Donor data. Matched images.
TriStar’s Oncology Translational Pathology Repository
Ethically sourced
Informed consent and ethics approval support our established tissue collections.
Quality assurance
Medical pathologists help assess tissue suitability for your study.
FFPE tissue & cohorts
Linked donor dataSelect primary, metastatic and non-malignant tissue by indication, biomarker profile and treatment history.
indications
Tissue microarrays
Linked donor dataExplore multi-tumor, normal tissue and indication-specific TMAs, including selected treatment-linked collections.
the catalog
Matched plasma & tissue
Linked donor dataDouble-spun plasma with matched FFPE tissue in selected collections, with buffy coat requirements discussed for your study.
indications
Linked across our sample collections
Images & clinical data
FFPE tissue, TMAs and matched plasma connect to clinical and molecular records from the same donors.
- Treatment history & recorded response
- Survival & clinical follow-up
- Clinical & molecular characterization
- Donors in the image repository
- 30,000+
- H&E whole-slide images
- 100,000+
- Scanning magnification
- 40×
- Image file format
- .SVS
Records are anonymized. Sample matching and available data vary by donor and collection.
Tissue microarrays
An expansive collection of unique Tissue Microarrays
Scientifically relevant tissue microarrays developed from strategically collected human tissue and research collaborations. Explore collections with treatment follow-up and molecular data, including selected RNAscope-prequalified arrays.
- Collection breadthMulti-tumor, normal tissue, tumor-specific and variant-specific TMAs
- Clinical follow-upTreatment, response and survival information in selected collections
- Molecular contextSelected arrays with IHC, NGS or RNA-seq data
Beyond the specimen
Anonymized donor records with clinical & molecular data
Specimen, treatment, outcomes and molecular data, structured at the patient level. Select cases using the clinical history and follow-up relevant to your research.
Patient trajectory
- Primary tumors & matched distant metastases
- Matched normal tissue
- Neoadjuvant & adjuvant treatment
- Standard-of-care targeted therapies & checkpoint inhibitors
- Treatment regimen, line & dates
- Responders & non-responders
- Treatment-naïve & treated cases
Structured outcomes
- Clinician-recorded response
- Overall survival (months)
- Progression-free survival (months)
- Time to events (months)
- Last follow-up
- Event flags: recurrence / death / composite
Molecular characterization
- IHC
- FISH
- RNA-ISH
- NGS: SNVs, CNVs & fusions
Treatment context
- Checkpoint inhibitors & IO
- Antibodies & ADCs
- Kinase inhibitors
- CDK4/6 inhibitors
- PI3K/mTOR inhibitors
- PARP inhibitors
The integrated services approach
Samples, services and pathology expertise through one partner
Add laboratory services and pathology guidance to your repository request, coordinated around your study.
Start with the right samples
Repository tissue selected for your research, with assays and platform work added as needed.
Pathologists with pharma experience
Our medical pathologists guide your project from study planning through completion, advising on tissue selection, assay strategy and interpretation.
Coordinated tissue use and testing
Plan tissue allocation and laboratory work together, with one point of contact from sample selection through analysis.
Assays & pathology support
Choose the assays your study needs
Assay development, staining and pathology scoring, guided by pharmaceutical research experience.
Protein expression
IHC assay services
Add protein-expression measurements with 100+ optimized IHC assays, or discuss assay development for a new target.
Explore IHC servicesSpatial RNA expression
RNAscope RNA-ISH
Localize target RNA in FFPE tissue, with pre-qualified samples, assay controls and pathologist scoring.
Explore RNAscopeMultiplex protein imaging
Multiplex immunofluorescence
Study protein co-expression, cell phenotypes and spatial relationships in selected FFPE tissue and TMAs.
Additional profiling & analysis
Add molecular profiling or image analysis to your repository request.
Fewer handoffs
Spend less time coordinating samples and laboratory work across providers.
Pathology-informed decisions
Connect tissue suitability, assay selection and interpretation.
Coordinated sample use
Plan tissue allocation and additional work with one point of contact.
Research applications
Featured applications
Prevalence studies
Compare target expression across tumor types and non-malignant tissues using TMAs and FFPE cohorts.
ExploreImmuno-oncology
Study immune markers in pathologist-reviewed tissue, with treatment history and response data in selected collections.
ExploreTargeted cancer therapeutics
Explore target expression and resistance mechanisms in tissue with available mutation status and molecular data.
ExploreADCs & bispecifics
Explore tissue and target-expression datasets for antibody research, with available treatment and follow-up data.
ExploreWork with our experienced scientific team to tailor biospecimens, data, and integrated services to your research needs.
Our approach begins with our customers’ science.
We focus our acquisition on patient cohorts that meet the needs of biopharma, clinical, and translational researchers.
Plan your study
Define your cohort and study requirements
Share your indication, sample format, cohort size and required clinical or molecular information. Our team will help you explore the relevant collections and additional work.